ArticleBMC musculoskeletal disorders2025

Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis.

Yi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.